https://www.selleckchem.com/pr....oducts/l-nmma-acetat
70, 95% confidence interval (CI) 1.71-4.28, p 0.001) and OS (HR 2.79, 95% CI 1.63-4.77, p 0.001), while moderately obese, slightly obese and overweight patients did not differ from underweight/normal weight patients with regard to DFS or OS. Subgroup analyses showed a similar significant effect of BMI on DFS and OS in patients with triple-negative breast cancer (TNBC), but not in patients with other tumor subtypes. Severe obesity (BMI ≥ 4 significantly worsens prognosis in early breast cancer patients, particularly fo
Like
Comment
Share
